The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis

被引:40
|
作者
Gao, Fei [1 ]
Zhou, Bin [2 ]
Xu, Jun-Chi [3 ]
Gao, Xin [1 ]
Li, Shu-Xiang [1 ]
Zhu, Geng-Chao [1 ]
Zhang, Xue Guang [2 ]
Yang, Chen [1 ]
机构
[1] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou 215000, Jiangsu, Peoples R China
[2] Soochow Univ, Inst Clin Immunol Jiangsu Prov, Suzhou 215007, Peoples R China
[3] Fifth Peoples Hosp Suzhou, Suzhou, Jiangsu, Peoples R China
关键词
LGR5; ALDH1A1; NSCLC; Clinical pathology; Prognosis; STEM-CELLS; EXPRESSION; IDENTIFICATION; PROMISE; MARKER; COLON;
D O I
10.1016/j.bbrc.2015.04.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Leucine rich repeat containing G protein coupled receptor 5 (LGR5), may be a candidate marker of non-small cell lung cancer (NSCLC) cells with stem cell-like properties. Aldehyde dehydrogenase 1A1 (ALDH1A1) is one of NSCLC stem cell markers. To identify the relationship of LGR5 and ALDH1A1 in NSCLC, we analyzed the expression of LGR5 and ALDH1A1 in NSCLC samples, and determined their clinical significance. We performed quantitative RT-PCR for LGR5 and ALDH1A1 expression in 24 NSCLC patients, and showed that LGR5 and ALDH1A1 mRNA were frequently increased in NSCLC tissues in comparison to that in adjacent normal tissues (p = 0.0005 and p < 0.0001, respectively). Besides, the expression of LGR5 and ALDH1A1 mRNA has a significant correlation (r = 0.416, P = 0.0483). The expression of LGR5 and ALDH1A1 in 109 NSCLC tumors and 50 adjacent normal tissues were detected by immunohistochemistry. Positive LGR5 and ALDH1A1 expression was defined in 28.4% and 41.3% of the NSCLC tumors, respectively. Further analysis indicated that 24 of these LGR5(+) (24/31) samples expressed ALDH1A1(r = 0.3883, p < 0.0001), we also found co-localization of LGR5 and ALDH1A1 in tumor tissue samples. LGR5 and ALDH1A1 expression was significantly associated with higher pathological TNM stage of the disease (stage I + II and III + IV) (P = 0.0311 and p = 0.0221, respectively), the co-expression of LGR5 and ALDH1A1 was associated with nodal status (p = 0.0424). High expression of LGR5 or ALDH1A1 was related to poor prognosis (P = 0.0125 and p = 0.0410, respectively), and NSCLC patients with co-expression of LGR5 and ALDH1A1 had a poorer prognosis than the others (P = 0.0011). Both of them can be an independent risk factor of a poorer prognosis (P = 0.016 and P = 0.024, respectively). The expression of LGR5 and ALDH1A1 were closely associated with the tumorigenicity, metastasis and poor prognosis of NSCLC, and LGR5+ cells in NSCLC were likely to be the cancer cells with stem cell-like properties due to the significant correlation between LGR5 and ALDH1A1. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [21] GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
    Feng, Yong
    Li, Na
    Ren, Yi
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2419 - 2428
  • [22] Notch 1 and Notch 3 and prognosis of resected non-small cell lung cancer
    Cho, E.
    Ha, S.
    Park, S.
    Lee, J.
    Park, J.
    Jung, S.
    Sym, S.
    Shin, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Notch 1 and Notch 3 for Prognosis of Resected Non-Small Cell Lung Cancer
    Cho, Eun Kyung
    Ha, Seung Yeon
    Park, Sanghui
    Hong, Junshick
    Sym, Sun Jin
    Park, Jinny
    Lee, Jae-Ik
    Shin, Dong Bok
    Lee, Jae Hoon
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S421 - S421
  • [24] The prognostic roles of circulating ALDH1+ tumor cell in the patients with non-small cell lung cancer
    Tian, Shuang
    Xing, Ya-Nan
    Xia, Pu
    BIOSCIENCE REPORTS, 2018, 38
  • [25] The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer
    Guo, Qiang
    Wang, Si-hua
    Ji, Yan-mei
    Tong, Song
    Li, Dan
    Ding, Xiang-chao
    Wu, Chuang-yan
    CURRENT MEDICAL SCIENCE, 2022, 42 (06) : 1186 - 1200
  • [26] SUMO-1 expression modulates non-small cell lung cancer progression
    Ke, Changkang
    Zhu, Kai
    Sun, Ying
    Zhang, Zhipei
    Ni, Yunfeng
    Li, Xiaofei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 6054 - +
  • [27] Bmi-1 expression modulates non-small cell lung cancer progression
    Xiong, Dan
    Ye, Yunlin
    Fu, Yujie
    Wang, Jinglong
    Kuang, Bohua
    Wang, Hongbo
    Wang, Xiumin
    Zu, Lidong
    Xiao, Gang
    Hao, Mingang
    Wang, Jianhua
    CANCER BIOLOGY & THERAPY, 2015, 16 (05) : 756 - 763
  • [28] Overexpression of CUGBP1 is associated with the progression of non-small cell lung cancer
    Gao, Caihong
    Yu, Zhuang
    Liu, Shihai
    Xin, Hou
    Li, Xiumei
    TUMOR BIOLOGY, 2015, 36 (06) : 4583 - 4589
  • [29] The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer
    Qiang Guo
    Si-hua Wang
    Yan-mei Ji
    Song Tong
    Dan Li
    Xiang-chao Ding
    Chuang-yan Wu
    Current Medical Science, 2022, 42 (6) : 1186 - 1200
  • [30] The role of ATP8A1 in non-small cell lung cancer
    Li, Daowei
    Xu, Tao
    Wang, Xingguang
    Ma, Xiaobin
    Liu, Tingting
    Wang, Yonggang
    Jiang, Shujuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (07): : 7760 - 7766